Challenges and Considerations in Prescribing CGRP Inhibitors for Migraine Treatment

This chapter explores the difficulties of prescribing CGRP pathway medicine for migraine treatment, including the lack of biological predictors for response and patients' varying levels of satisfaction. It also emphasizes the importance of considering availability and insurance coverage when choosing a CGRP inhibitor, and the significance of including patient preferences in treatment decisions.